Welcome to our dedicated page for Lifecore Biomedical SEC filings (Ticker: LFCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. SEC filings for Lifecore Biomedical, Inc. (NASDAQ: LFCR), a Delaware corporation based in Chaska, Minnesota that operates as a fully integrated CDMO focused on sterile injectable pharmaceuticals and injectable-grade hyaluronic acid. These regulatory documents offer detailed insight into how the company reports its operations, governance, and financial condition.
Through filings such as the annual report on Form 10-K and quarterly reports on Form 10-Q, investors can review discussions of Lifecore’s CDMO and HA manufacturing activities, risk factors, and management’s analysis of results. Current reports on Form 8-K highlight specific events, including financial results announcements, changes in independent registered public accounting firms, investor presentations used in discussions with analysts, and matters submitted to a stockholder vote at the annual meeting.
The definitive proxy statement on Form DEF 14A describes corporate governance topics such as director elections, auditor ratification, and advisory votes on executive compensation, as well as stock ownership and compensation discussion and analysis. Other filings may address compensation plans and incentive structures, including bonus plans tied to metrics like Adjusted EBITDA and total revenue, as described in the company’s disclosures.
On Stock Titan, these filings are updated from the SEC’s EDGAR system and can be paired with AI-powered summaries that help explain complex sections, highlight key changes, and clarify terminology. Users can quickly identify items related to financial performance, internal control matters, auditor changes, and stockholder voting outcomes without reading every page. For those interested in governance, accounting, or the details behind Lifecore’s CDMO and HA manufacturing business, this filings page serves as a structured entry point into the company’s official regulatory record.